A decades-long study at the University of Arizona Health Sciences Asthma and Airway Disease Research Center is improving lung health through research.Continue reading→

PHOENIX — Current screening protocols fail to catch a notable number of people carrying genetic mutations associated with hereditary breast and ovarian cancer syndrome and Lynch syndrome, which increase the risk of developing certain cancers. This issue is particularly pronounced among underrepresented minorities. Continue reading→

Phoenix based Flambeau Medical , a full-service contract manufacturing organization serving the medical device and life sciences industries, has added a new industrial 3D printer to expand its rapid prototyping services.Continue reading→

Arizona’s health innovation community generated $38.54 billion in economic impact in 2021 and has set a goal double that impact by 2033.  AZAdvances with its focus on workforce development and  supporting the growth of Arizona life science companies is a key component of this growth strategy. Continue reading→

The Phoenix Bioscience Core (PBC) Team is expanding! With the invaluable support of key stakeholders, we are launching two new initiatives: An Accelerator Program and Workforce Development initiative. Increasing our healthcare workforce and catering to life science startups and Venture Capital are fundamental economic development tools that enhance Arizona’s economy. These initiatives mark a significant step forward in our commitment to fostering growth and innovation within our community.Continue reading→

Multi-omics study looks at response to neddylation (NAE) inhibitor drugsContinue reading→

NuvOx Pharma LLC (“NuvOx”) announced that it has received authorization from Health Canada for its EXTEND: novEl oXygen ThErapeutic NanO2 for mild respiratory distress in Phase Ib and ARDS in Phase II TrialsContinue reading→

New study explores the machinery of gene regulation: The tiny roundworm C.elegans is the focus of a new study examining 3’UTRs. These short segments of RNA play a critical role in the regulation of genes. The resulting map, the product of 20 years of research, is the most complete dataset of its kind for any animal, and will help advance basic understanding of mechanisms of gene regulation critical in human health and disease. Continue reading→

The University of Arizona Health Sciences Center for Advanced Molecular and Immunological Therapies will receive more than $20 million in funding from the Phoenix City Council following a unanimous vote of support.Continue reading→